Summary of novel genes
| Entity | Tier 1 genes | Tier 2 genes | Tier 3 genes |
|---|---|---|---|
| DLBCL | 1 | 0 | 0 |
---
config:
sankey:
showValues: true
linkColor: target
width: 600
height: 300
nodeAlignment: right
prefix: '('
suffix: ' genes)'
---
sankey-beta
This study, New Tier 1, 1
New Tier 1, DLBCL Tier 1, 1
This study, New Tier 2, 0
New Tier 2, DLBCL Tier 2, 0
This study, New Tier 3, 0
New Tier 3, DLBCL Tier 3, 0
All other DLBCL studies, DLBCL Tier 1, 124
All other DLBCL studies, DLBCL Tier 2, 210
All other DLBCL studies, DLBCL Tier 3, 387
Novel genes reported in this study
Tier 1
| New gene | DLBCL tier |
|---|---|
| MYD88 | 1 |
Details
Ngo, Vu N., Ryan M. Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao,
Kian-Huat Lim, Holger Kohlhammer, et al. 2011. “Oncogenically
Active Myd88 Mutations in Human Lymphoma.”
Nature 470 (7332): 115–19. https://doi.org/10.1038/nature09671.
